NO162069C - Analogifremgangsmaate for fremstilling av 1h-indol-3-yl inneholdende 1,3-di-metyl-1h-purin-2,6-dioner. - Google Patents

Analogifremgangsmaate for fremstilling av 1h-indol-3-yl inneholdende 1,3-di-metyl-1h-purin-2,6-dioner.

Info

Publication number
NO162069C
NO162069C NO853856A NO853856A NO162069C NO 162069 C NO162069 C NO 162069C NO 853856 A NO853856 A NO 853856A NO 853856 A NO853856 A NO 853856A NO 162069 C NO162069 C NO 162069C
Authority
NO
Norway
Prior art keywords
indol
preparing
purin
dione
methyl
Prior art date
Application number
NO853856A
Other languages
English (en)
Norwegian (no)
Other versions
NO853856L (no
NO162069B (no
Inventor
Ludo Edmond Josephine Kennis
Jan Vandenberk
Jozef Martin Boey
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO853856L publication Critical patent/NO853856L/no
Publication of NO162069B publication Critical patent/NO162069B/no
Publication of NO162069C publication Critical patent/NO162069C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
NO853856A 1984-10-01 1985-09-30 Analogifremgangsmaate for fremstilling av 1h-indol-3-yl inneholdende 1,3-di-metyl-1h-purin-2,6-dioner. NO162069C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/656,561 US4548939A (en) 1984-10-01 1984-10-01 1H-Indol-3-yl containing 1,3-dimethyl-1H-purine-2,6-diones

Publications (3)

Publication Number Publication Date
NO853856L NO853856L (no) 1986-04-02
NO162069B NO162069B (no) 1989-07-24
NO162069C true NO162069C (no) 1989-11-01

Family

ID=24633577

Family Applications (1)

Application Number Title Priority Date Filing Date
NO853856A NO162069C (no) 1984-10-01 1985-09-30 Analogifremgangsmaate for fremstilling av 1h-indol-3-yl inneholdende 1,3-di-metyl-1h-purin-2,6-dioner.

Country Status (17)

Country Link
US (1) US4548939A (da)
EP (1) EP0177087B1 (da)
JP (1) JPH0653742B2 (da)
CN (1) CN1011311B (da)
AT (1) ATE60604T1 (da)
AU (1) AU576386B2 (da)
CA (1) CA1262348A (da)
DE (1) DE3581577D1 (da)
DK (1) DK163996C (da)
ES (1) ES8609324A1 (da)
FI (1) FI83220C (da)
GR (1) GR852375B (da)
IE (1) IE58747B1 (da)
NO (1) NO162069C (da)
NZ (1) NZ213498A (da)
PT (1) PT81229B (da)
ZA (1) ZA857553B (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH648559A5 (de) * 1981-07-20 1985-03-29 Siegfried Ag Theophyllinderivate und verfahren zu deren herstellung.
US4742057A (en) * 1985-12-05 1988-05-03 Fujisawa Pharmaceutical Co., Ltd. Antiallergic thiazole compounds
GB8719167D0 (en) * 1987-08-13 1987-09-23 Glaxo Group Ltd Chemical compounds
PH24976A (en) * 1987-08-13 1990-12-26 Glaxo Group Ltd Indole derivatives
DK733788A (da) * 1988-01-14 1989-07-15 Fujisawa Pharmaceutical Co Indolylpiperidinderivater og fremgangsmaade til fremstilling deraf
GB8819024D0 (en) * 1988-08-10 1988-09-14 Glaxo Group Ltd Chemical compounds
DE3843117A1 (de) * 1988-12-22 1990-06-28 Boehringer Ingelheim Kg Neue xanthinderivate mit adenosin-antagonistischer wirkung
DK292A (da) * 1991-11-29 1992-01-02 Tanisake Kk Middel
DE4414113A1 (de) * 1994-04-22 1995-10-26 Merck Patent Gmbh 3-Indolylpiperidine
WO2009002933A1 (en) * 2007-06-22 2008-12-31 Hydra Biosciences, Inc. Methods and compositions for treating disorders
WO2010039289A2 (en) 2008-05-14 2010-04-08 Hydra Biosciences, Inc. Compounds and compositions for treating chemical warfare agent-induced injuries
WO2009140517A1 (en) 2008-05-14 2009-11-19 Hydra Biosciences, Inc. Compounds and compositions for treating chemical warfare agent-induced injuries

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2322470A1 (de) * 1973-05-04 1974-11-21 Boehringer Sohn Ingelheim Neue indolyl-piperidino-(bzw. 1,2,5,6tetrahydro-pyridyl-)butyrophenone und verfahren zu ihrer herstellung
FR2334358A1 (fr) * 1975-12-12 1977-07-08 Sogeras Nouveaux medicaments derives de l'indole
FR2362628A1 (fr) * 1976-08-26 1978-03-24 Roussel Uclaf Nouveaux derives du piperidyl-indole et leurs sels, procede de preparation et application a titre de medicaments
EP0011399A1 (en) * 1978-11-11 1980-05-28 FISONS plc N-substituted theophyllines, processes for their preparation and pharmaceutical compositions containing them
DE2922159A1 (de) * 1979-05-31 1980-12-04 Boehringer Mannheim Gmbh Neue xanthin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
US4342870A (en) * 1980-03-28 1982-08-03 Janssen Pharmaceutica N.V. Novel 3-(1-piperidinylalkyl)-4H-pyrido[1,2-a]pyrimidin-4-one derivatives
US4426383A (en) * 1980-09-04 1984-01-17 Eisai Co., Ltd. Theophylline and theobromine derivatives
US4359468A (en) * 1981-02-25 1982-11-16 Boehringer Ingelheim Ltd. Antiallergic N-[4-(indolyl)-piperidino-alkyl]-benzimidazolones
US4443451A (en) * 1981-07-15 1984-04-17 Janssen Pharmaceutica N.V. Bicyclic pyrimidin-5-one derivatives
CH648559A5 (de) * 1981-07-20 1985-03-29 Siegfried Ag Theophyllinderivate und verfahren zu deren herstellung.

Also Published As

Publication number Publication date
JPS6187681A (ja) 1986-05-06
DE3581577D1 (de) 1991-03-07
DK163996B (da) 1992-04-27
NZ213498A (en) 1988-04-29
AU4812485A (en) 1986-04-10
DK163996C (da) 1992-09-21
ES8609324A1 (es) 1986-07-16
NO853856L (no) 1986-04-02
FI853763L (fi) 1986-04-02
AU576386B2 (en) 1988-08-25
PT81229B (pt) 1987-11-30
NO162069B (no) 1989-07-24
ZA857553B (en) 1987-05-27
CA1262348A (en) 1989-10-17
FI83220C (fi) 1991-06-10
CN1011311B (zh) 1991-01-23
IE58747B1 (en) 1993-11-03
US4548939A (en) 1985-10-22
PT81229A (en) 1985-11-01
EP0177087A3 (en) 1986-06-11
FI83220B (fi) 1991-02-28
IE852403L (en) 1986-04-01
JPH0653742B2 (ja) 1994-07-20
EP0177087A2 (en) 1986-04-09
ES547447A0 (es) 1986-07-16
CN85105804A (zh) 1986-10-22
DK444085D0 (da) 1985-09-30
GR852375B (da) 1986-01-31
DK444085A (da) 1986-04-02
FI853763A0 (fi) 1985-09-30
EP0177087B1 (en) 1991-01-30
ATE60604T1 (de) 1991-02-15

Similar Documents

Publication Publication Date Title
ES8706668A1 (es) Un procedimiento para la preparacion de derivados de piperidina.
ES8603870A1 (es) Un procedimiento para la preparacion de derivados de 2,2'-iminobisetanol.
PH21554A (en) N-(4-piperidinyl)bicyclic condensed-2-imidazolamine derivatives
HUT42095A (en) Process for producing purine ring or analogue ring-systhems /heteropurine/-containing compounds and pharmaceutical compositions containing them
PH25504A (en) Novel substituted n-(1-alkyl-3-hydroxy-4-piperidinyl)benzamides pharmaceutical composition containing said compound, method of use thereof
AU576386B2 (en) 1h-indol-3-yl containing 1,3-dimethyl-1h-purine-2,6-diones
ES552593A0 (es) Un procedimiento para preparar derivados de aminoacidos
EP0184258A3 (en) Novel derivatives of hydroxy- or amino-substituted (piperidinylalkyl)quinazolines
HUT53664A (en) Process for producing enzyme inhibiting amino acid derivatives and pharmaceutical compositions comprising such compounds as active ingredient
ZA857173B (en) Amide derivatives
MY101266A (en) Pharmaceutical formulations
HUT51622A (en) Process for producing 3-piperidinole-indazole derivatives and pharmaceutical preparations having effect against high blood pressure containing these compounds as active substance